Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An emergent disease-associated motor neuron state precedes cell death in ALS.

Cell·2026
Same author

The contactin rig-6 transiently promotes GABA neuron remodeling with a sustained impact on male mating behavior in C. elegans.

Genetics·2026
Same author

Cryptic splicing in synaptic and membrane excitability genes links TDP-43 loss to neuronal dysfunction.

Science translational medicine·2026
Same author

Whole-genome 3D architectural screen reveals modulators of brain DNA structure.

bioRxiv : the preprint server for biology·2026
Same author

Granulin loss and TMEM106B risk converge on lysosomal C-terminal fragment pathology in frontotemporal dementia.

bioRxiv : the preprint server for biology·2026
Same author

KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS.

JCI insight·2026

Related Experiment Video

Updated: Jun 2, 2026

Growth Assays to Assess Polyglutamine Toxicity in Yeast
09:06

Growth Assays to Assess Polyglutamine Toxicity in Yeast

Published on: March 5, 2012

A yeast model for polyalanine-expansion aggregation and toxicity.

Catherine A Konopka1, Melissa N Locke, Pamela S Gallagher

  • 1Department of Pharmacology, University of Washington, Seattle, USA.

Molecular Biology of the Cell
|April 22, 2011
PubMed
Summary

Polyalanine (polyA) expansions in proteins cause human diseases. Yeast studies show longer polyA expansions in Pab1 protein lead to distinct toxic mechanisms, highlighting the need for varied research approaches.

More Related Videos

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

Evaluation of the Impact of Protein Aggregation on Cellular Oxidative Stress in Yeast
11:04

Evaluation of the Impact of Protein Aggregation on Cellular Oxidative Stress in Yeast

Published on: June 23, 2018

Related Experiment Videos

Last Updated: Jun 2, 2026

Growth Assays to Assess Polyglutamine Toxicity in Yeast
09:06

Growth Assays to Assess Polyglutamine Toxicity in Yeast

Published on: March 5, 2012

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

Evaluation of the Impact of Protein Aggregation on Cellular Oxidative Stress in Yeast
11:04

Evaluation of the Impact of Protein Aggregation on Cellular Oxidative Stress in Yeast

Published on: June 23, 2018

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Nine human disorders are linked to toxic protein aggregation caused by polyalanine (polyA) expansions.
  • PolyA tracts are common in eukaryotic proteins, suggesting broad implications for expansion-related diseases.

Purpose of the Study:

  • To investigate the general cytotoxicity of polyA expansions using yeast as a model organism.
  • To explore the impact of varying polyA tract lengths on protein aggregation and cellular toxicity.

Main Methods:

  • Expanded the polyA tract in the native yeast poly(Adenine)-binding protein (Pab1) to lengths of 13A, 15A, 17A, and 20A.
  • Assessed Pab1 inclusions, insolubility, and cytotoxicity.
  • Manipulated RNA binding and cytoplasmic mRNA levels to test their role in toxicity.

Main Results:

  • Increasing polyA expansion length in Pab1 correlated with greater inclusion formation, insolubility, and cytotoxicity.
  • Disrupting RNA binding or altering mRNA levels suppressed the toxicity of 17A-expanded Pab1, indicating mRNA's role.
  • These manipulations did not suppress the cytotoxicity of 20A-expanded Pab1, suggesting a different toxic mechanism for longer expansions.

Conclusions:

  • PolyA expansion length influences the mechanism of protein toxicity.
  • Shorter polyA expansions may exert toxicity through RNA-dependent pathways.
  • Longer polyA expansions might employ distinct cytotoxic mechanisms, necessitating separate investigation.